Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach

. 2012 Sep ; 57 (5) : 421-30. [epub] 20120508

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu hodnotící studie, časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid22566119

Although invasive fungal diseases (IFDs) are relatively rare, they have become an increasingly common life-threatening complication in a variety of critically ill patients. Due to changes in treatment strategies, patterns of IFDs have changed substantially as well. Yeast infections have shifted toward a higher proportion of non-albicans Candida species, but their overall incidence has remained stable. In contrast, IFDs caused by molds, including particularly various species of Aspergillus, Fusarium, and Mucorales, have increased in number. In view of the growing incidence and the high mortality rates of IFDs, accurate diagnostic techniques permitting timely onset of adequate antifungal treatment are of paramount importance. Although conventional approaches such as microscopy, cultivation, histopathological examination, and imaging methods still represent the gold standard, the diagnosis remains difficult because of limited sensitivity and specificity. Noninvasive and culture-independent diagnostic techniques, including fungal antigen detection, and different molecular-based techniques are becoming increasingly important. Of the fungal surrogate markers such as cell wall components, galactomannan and (1,3)-β-D-glucan by commercially available diagnostic kits have become widely used, but the results are still controversial. A plethora of PCR-based diagnostic methods targeting different gene regions and exploiting a variety of amplicon detection tools have been published. Molecular assays have the capacity to overcome the limitations of other diagnostic approaches, but the current lack of methodological standardization and validation, together with not always clear interpretation of the results, has prevented broad application in the clinical setting.

Zobrazit více v PubMed

Clin Infect Dis. 2005 Sep 1;41(5):654-9 PubMed

Bone Marrow Transplant. 2006 May;37(9):857-64 PubMed

Curr Opin Oncol. 2010 Mar;22(2):138-42 PubMed

J Clin Microbiol. 2005 Jan;43(1):299-305 PubMed

J Clin Oncol. 2009 Jul 10;27(20):3398-409 PubMed

Bone Marrow Transplant. 2005 Feb;35(3):303-6 PubMed

Exp Dermatol. 2009 Oct;18(10):880-2 PubMed

N Engl J Med. 1991 Apr 11;324(15):1026-31 PubMed

Clin Vaccine Immunol. 2008 Jul;15(7):1132-3 PubMed

Drug Resist Updat. 2010 Dec;13(6):180-95 PubMed

Med Mycol. 2011 Jan;49(1):73-9 PubMed

Cancer. 2009 Jan 15;115(2):355-62 PubMed

Clin Infect Dis. 2004 Jul 15;39(2):199-205 PubMed

Lancet. 2003 Nov 29;362(9398):1828-38 PubMed

Expert Rev Mol Diagn. 2009 Jul;9(5):397-401 PubMed

Med Mycol. 2006 Dec;44(8):733-9 PubMed

Curr Infect Dis Rep. 2007 Nov;9(6):465-71 PubMed

Cancer. 2002 Feb 15;94(4):1032-6 PubMed

J Clin Microbiol. 2006 Nov;44(11):3894-9 PubMed

J Clin Microbiol. 1999 Dec;37(12):3865-71 PubMed

BMC Infect Dis. 2007 Sep 04;7:103 PubMed

Med Mycol. 2009;47 Suppl 1:S282-90 PubMed

J Microbiol Immunol Infect. 2007 Apr;40(2):148-53 PubMed

Am J Med. 2012 Jan;125(1 Suppl):S14-24 PubMed

Med Mycol. 2011 Nov;49(8):856-63 PubMed

J Med Microbiol. 2007 Sep;56(Pt 9):1167-1173 PubMed

Clin Microbiol Infect. 2011 Apr;17(4):546-51 PubMed

Clin Microbiol Infect. 2008 May;14 Suppl 4:5-24 PubMed

Mycoses. 2010 Jan;53(1):1-11 PubMed

Microbiol Immunol. 1993;37(3):207-12 PubMed

Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):613-22 PubMed

Future Microbiol. 2010 Nov;5(11):1733-54 PubMed

Pediatr Rep. 2011 Jun 16;3(2):e14 PubMed

Mycoses. 2009 May;52(3):197-205 PubMed

J Infect Dis. 2002 Apr 15;185(8):1203-6 PubMed

Am J Clin Pathol. 2004 Jan;121(1):18-25 PubMed

J Clin Microbiol. 1997 Sep;35(9):2206-9 PubMed

Lancet Infect Dis. 2009 Feb;9(2):89-96 PubMed

Clin Microbiol Rev. 2002 Jul;15(3):465-84 PubMed

BMC Infect Dis. 2011 Mar 09;11:60 PubMed

Infect Dis Clin North Am. 2010 Jun;24(2):439-59 PubMed

Intern Med. 2011;50(22):2783-91 PubMed

Clin Infect Dis. 2008 Feb 1;46(3):327-60 PubMed

J Clin Microbiol. 2007 Mar;45(3):906-14 PubMed

Rev Iberoam Micol. 2006 Dec;23(4):209-15 PubMed

Crit Care Med. 2010 Aug;38(8 Suppl):S380-7 PubMed

Leukemia. 2010 Dec;24(12):2032-8 PubMed

J Clin Microbiol. 1994 Jan;32(1):228-31 PubMed

Med Mycol. 1998 Oct;36(5):275-9 PubMed

J Mol Diagn. 2006 Jul;8(3):376-84 PubMed

Clin Infect Dis. 2007 May 15;44(10):1329-36 PubMed

Clin Microbiol Infect. 2012 May;18(5):475-84 PubMed

Minerva Ginecol. 2007 Jun;59(3):311-29 PubMed

Clin Infect Dis. 2008 Jun 15;46(12):1930-1 PubMed

Immunol Lett. 2007 Mar 15;109(1):76-82 PubMed

J Clin Microbiol. 2008 Jun;46(6):1919-26 PubMed

Clin Infect Dis. 2009 Dec 1;49(11):1650-9 PubMed

Cochrane Database Syst Rev. 2008 Oct 08;(4):CD007394 PubMed

Clin Infect Dis. 2004 Mar 15;38(6):913-6 PubMed

Hum Immunol. 2007 Jan;68(1):41-50 PubMed

Med Mycol. 2007 Mar;45(2):97-121 PubMed

Clin Microbiol Infect. 2011 Dec;17(12):E27-9 PubMed

Clin Infect Dis. 2012 Mar 1;54(5):633-43 PubMed

J Clin Oncol. 2002 Apr 1;20(7):1898-906 PubMed

Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5 PubMed

J Infect Dis. 2006 Mar 1;193(5):741-7 PubMed

Diagn Microbiol Infect Dis. 2005 Feb;51(2):95-101 PubMed

J Clin Microbiol. 2005 Nov;43(11):5828-9 PubMed

J Clin Microbiol. 2010 Mar;48(3):900-7 PubMed

J Clin Microbiol. 2005 Dec;43(12):5957-62 PubMed

Clin Microbiol Infect. 2008 May;14 Suppl 4:37-45 PubMed

Clin Infect Dis. 2001 May 1;32(9):1319-24 PubMed

J Clin Microbiol. 2007 Nov;45(11):3743-53 PubMed

Diagn Microbiol Infect Dis. 2011 Jul;70(3):330-43 PubMed

Clin Microbiol Infect. 2009 Jul;15(7):625-33 PubMed

Eur J Med Res. 2002 May 31;7(5):236-41 PubMed

Transpl Infect Dis. 2002;4 Suppl 3:32-7 PubMed

J Clin Microbiol. 2007 Sep;45(9):3141-2 PubMed

Antimicrob Agents Chemother. 2006 Oct;50(10):3450-3 PubMed

Infect Dis Clin North Am. 2006 Sep;20(3):711-27, viii PubMed

J Clin Microbiol. 2005 Oct;43(10):5122-8 PubMed

J Clin Microbiol. 2006 Mar;44(3):693-9 PubMed

Am J Infect Control. 2007 Apr;35(3):183-9 PubMed

J Clin Microbiol. 1996 Aug;34(8):1918-21 PubMed

N Engl J Med. 2008 Oct 23;359(17):1766-77 PubMed

Am J Med. 1995 Aug;99(2):164-72 PubMed

Clin Microbiol Infect. 2012 Nov;18(11):1117-25 PubMed

Am J Med. 2012 Jan;125(1 Suppl):S3-13 PubMed

J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i15-24 PubMed

Pediatr Infect Dis J. 2009 Aug;28(8):734-7 PubMed

J Clin Microbiol. 2010 Oct;48(10):3648-53 PubMed

Clin Infect Dis. 2008 Jun 15;46(12):1864-70 PubMed

J Clin Pathol. 1996 Oct;49(10):798-801 PubMed

Drug Resist Updat. 2011 Jun;14(3):164-76 PubMed

J Clin Microbiol. 2009 Apr;47(4):1063-73 PubMed

Clin Infect Dis. 2008 Jun 15;46(12):1813-21 PubMed

J Clin Microbiol. 2012 Jan;50(1):7-15 PubMed

Clin Microbiol Infect. 2010 Sep;16(9):1328-34 PubMed

Am J Med Sci. 2010 Sep;340(3):253-7 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace